These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Musculoskeletal Infection in Orthopaedic Trauma: Assessment of the 2018 International Consensus Meeting on Musculoskeletal Infection. Obremskey WT; Metsemakers WJ; Schlatterer DR; Tetsworth K; Egol K; Kates S; McNally M; ; J Bone Joint Surg Am; 2020 May; 102(10):e44. PubMed ID: 32118653 [TBL] [Abstract][Full Text] [Related]
12. [Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis]. Chen H; Zhang H; Wang K; Yao Y; Xiao X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):930-932. PubMed ID: 31537213 [TBL] [Abstract][Full Text] [Related]
13. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700 [TBL] [Abstract][Full Text] [Related]
14. Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use. Auer JA; Goodship A; Arnoczky S; Pearce S; Price J; Claes L; von Rechenberg B; Hofmann-Amtenbrinck M; Schneider E; Müller-Terpitz R; Thiele F; Rippe KP; Grainger DW BMC Musculoskelet Disord; 2007 Aug; 8():72. PubMed ID: 17678534 [TBL] [Abstract][Full Text] [Related]
15. Using the Capture-Recapture Technique to Estimate the Ascertainment-Corrected Incidence of Musculoskeletal Injuries During Marine Corps Recruit Training. Lovalekar M; Keenan KA; Cruz DE; McFadden BA; Montgomery S; Arent SM; Nindl BC Mil Med; 2024 Jun; 189(Supplement_2):30-37. PubMed ID: 38920034 [TBL] [Abstract][Full Text] [Related]
16. Defining the volume of consultations for musculoskeletal infection encountered by pediatric orthopaedic services in the United States. Koehler RJ; Shore BJ; Hedequest D; Heyworth BE; May C; Miller PE; Rademacher ES; Sanborn RM; Murphy JS; Roseman A; Stoneback JW; Trizno AA; Goldstein RY; Harris L; Nielsen E; Talwar D; Denning JR; Saaed N; Kutz B; Laine JC; Naas M; Truong WH; Rotando M; Spence DD; Brighton BK; Churchill C; Janicki JA; King K; Wild J; Beebe AC; Crouse S; Rough T; Rowan M; Singh S; Davis-Juarez A; Gould A; Hughes O; Rickert KD; Upasani VV; Blumberg TJ; Bompadre V; Lindberg AW; Miller ML; Hill JF; Peoples H; Rosenfeld SB; Turner R; Copley LA; Lindsay EA; Ramo BA; Tareen N; Winberly RL; Li GY; Sessel J; Johnson ME; Johnson S; Moore-Lotridge SN; Shelton J; Baldwin KD; Schoenecker JG; PLoS One; 2020; 15(6):e0234055. PubMed ID: 32497101 [TBL] [Abstract][Full Text] [Related]
17. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney C; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ngozi Ekeke O; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis CJ; Mahal BA; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Pablo Sade J; Sartor OA; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A Eur Urol; 2023 Mar; 83(3):267-293. PubMed ID: 36494221 [TBL] [Abstract][Full Text] [Related]
18. Predictive utility of commercial grade technologies for assessing musculoskeletal injury risk in US Marine Corps Officer candidates. Bird MB; Koltun KJ; Mi Q; Lovalekar M; Martin BJ; Doyle TLA; Nindl BC Front Physiol; 2023; 14():1088813. PubMed ID: 36733913 [TBL] [Abstract][Full Text] [Related]